Skip to content

Clinical trials

Phase 1 Dermatitis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dermatitis Phase: Phase 1 Country / region: United States Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20101
20111
20183
20201
20221
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated4
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Regeneron Pharmaceuticals2
Attovia Therapeutics Inc1
Brigham and Women's Hospital1
Concerto Biosciences1
Mayo Clinic1
National Cancer Institute (NCI)1
National Institute of Allergy and Infectious Diseases (NIAID)1
Pfizer1
Rutgers, The State University of New Jersey1
Stanford University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dermatitis12
Dermatitis, Atopic5
Eczema2
Anus Neoplasms1
Blister1
Immunologic Deficiency Syndromes1
Job Syndrome1
Pruritus1
Psoriasis1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.